| abstract |
The enteric coated pharmaceutical dosage form comprises at least two portions of an H + inhibitor; K + -ATPase that is released in at least two consecutive pulses. The dosage form has at least one pulse delayed release fraction and another immediate release fraction of the H + inhibitor; K + -ATPase. The proportions are released over a period of from 0.5 to 12 hours, preferably from 0.5 to 8 hours, and particularly preferably from 0.5 to 4 hours. The dosage form is for administration once a day |